GNPX - Genprex, Inc.
Genprex, Inc.
3300 Bee Cave Road
Suite 650-227
Austin, TX 78746
United States
(877) 774-4679
https://www.genprex.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 28
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. John Rodney Varner | Co-Founder, Chairman, Pres & CEO | 886.97k | N/A | 1957 |
| Mr. Ryan M. Confer M.S. | Chief Financial Officer | 606.57k | N/A | 1982 |
| Ms. Catherine M. Vaczy Esq. | Exec. VP, Gen. Counsel, Corp. Sec. & Chief Strategy Officer | 704.93k | N/A | 1961 |
| Dr. Hemant Kumar C.P.M., EMBA, Ph.D. | Chief Manufacturing & Technology Officer | N/A | N/A | 1963 |
| Mr. David M. Schloss | Sr. VP of HR | N/A | N/A | N/A |
| Mr. Thomas C. Gallagher Esq. | Sr. VP of Intellectual Property & Licensing | N/A | N/A | N/A |
| Dr. William E. Gannon Jr. | Member of Clinical Advisory Board & VP of Regulatory Affairs | N/A | N/A | N/A |
| Dr. Mark S. Berger M.D. | Chief Medical Officer | N/A | N/A | 1955 |
| Dr. Jack A. Roth F.A.C.S., FACS, M.D. | Chairman of Scientific & Medical Advisory Board | N/A | N/A | N/A |
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
Corporate Governance
Genprex, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
